Chad Gwaltney PhD

Chad Gwaltney, Ph.D. is President and Principal Consultant at Gwaltney Consulting. Dr. Gwaltney develops innovative methods to measure patient-centered outcomes in clinical trials. His academic and industry research includes the design of electronic platforms for the collection of information in real-time in the patient’s natural environment. He has published numerous articles and book chapters addressing how the patient’s perspective can be examined to better understand medical product efficacy and safety. He has served on US National Institutes of Health review committees and has co-authored ISPOR best practice guidelines on the development and use of patient-reported outcomes. Prior to founding Gwaltney Consulting, Dr. Gwaltney was Chief Scientist and Regulatory Advisor, Endpoints, at ERT. Dr. Gwaltney has also served as Head, Patient Experience, Hematology/Oncology, at Celgene and as a research faculty member in the Brown University School of Public Health.